Who is immune to the invasion of the medical instrument industry's cross-border acquisition? 》
The M&A market has been calm for a long time. A weak market, a new tax system, and a shrinking tax rebate policy can all drive transactions. The flow of CEO-level personnel is very large, which usually indicates that companies are also inclined to merge. Everything seems to indicate that 2013 will set off a frenzy of mergers and acquisitions.
New taxation and health care reform are the incentives for acquisitions?
The financial crisis of 2009 has had a serious impact, bringing the consolidation and acquisition activities of the medical equipment industry to the bottom, but the situation is constantly changing. Industry executives and bankers say that they are now significantly different from 2009, the new US Tax systems and health care reform programs have also prompted large companies in medical equipment and equipment to start considering acquisitions and mergers.
Since 2012, the acquisition of medical technology and equipment has reached its lowest point in three years. According to Thomson Reuters data, as of August 28, 2012, the value of announced M&A transactions totaled $20 billion, far lower. In the same period last year, it was 53.32 billion US dollars. Among them are the closed trades in June, Johnson & Johnson (the world's second largest medical device manufacturer, also the largest foreign pharmaceutical company in China) bought $21 billion in surgical equipment manufacturer Synthes.
The new tax system for the US medical industry will come into effect in 2013. The new tax system is a fund to help health care reform, but it has also led large manufacturers in the medical industry to start sharpening their swords against small and medium-sized manufacturers.
St. Jude, one of the world's top ten medical devices, is seeing a bigger acquisition opportunity from the new tax system. “For some smaller companies, this will directly consume their "Some cash flow," St. Jude's chief financial officer John Heinmiller told reporters, "Other (small companies) stock prices will be affected, as well as other influences, which may lead them to become attractive targets."
For St. Jude and other big companies, government pressures can also cause financial problems. The weak economy also causes the patients to spend less money. It is very possible to seek innovative new products through mergers.
Medtronic Inc., the world's largest medical device manufacturer, is also considered a promising buyer. Medtronic CEO Omar Ishrak said the company has plans to acquire, but the acquisition will be very careful, not Any acquisition that damages profits will be made.
Unprecedented, large-scale high-level changes
Medtronic, Johnson & Johnson, Covi (Covidien, the world's sixth-largest medical device manufacturer) and Secker (the world's ninth largest medical device manufacturer) and other largest medical device manufacturers have changed in the past 18 months Losing their CEO, Boston Scientific (the world's seventh-largest medical device manufacturer) will also replace the CEO with Michael Mahoney, the former executive of Johnson & Johnson in November.
Grape Seed Extract Powder,Grape Skin Extract Powder,Hyaluronic Acid Sodium,Pine Bark Extract Capsules
Ningbo Nutrition Food Technology Co.,ltd. , https://www.collagenworkshop.com